Atlas Trials

The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

Clinical trial NCT00206557 · COMPLETED

Trial details

NCT number
NCT00206557
Sponsor
The Alfred
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Start date
2002-10-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.